Review Article
Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review
Table 1
Proposed mechanisms of tumor mediated immune evasion.
| Effects of tumor mediated immune evasion on T cells | Molecular mechanisms underlying tumor effects on T cells |
| Direct deletion of immune effector cells | Expression of death inducing ligand (Fas) | Secretion of immunosuppressive cytokines: IL-10, TGFβ |
| Direct tolerization of tumor reactive T cells | Cross presentation of tumor antigens by bone marrow APCs | B7-H1 expression by tumor and induction of T cell apoptosis |
| Inhibition of T cell activation or induction of anergy | Lack of expression of costimulatory molecules (CD 28 on T cells, B7 ligands on APCs) | Overexpression of inhibitory costimulatory molecules CTLA-4, PD-1, and PD-1 ligands |
|
|
IL: interleukin, TGF: tissue growth factor, APCs: antigen-presenting cells, B7-H1: B7-homolog 1, CTLA-4: cytotoxic T lymphocyte antigen, PD1: programmed death-1, PD-L1: programmed death-ligand 1, and VEGF: vascular endothelial growth factor.
|